Andrew Dudum, CEO of Hims & Hers

Hims CEO says he'd rather go af­ter ri­val­s' cus­tomers than buy their busi­ness­es

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

SAN FRAN­CIS­CO — For com­pa­nies that ad­ver­tise health­care ser­vices rang­ing from hair loss treat­ments to on­line ther­a­py di­rect­ly to con­sumers, it’s been ex­pen­sive in the last few years to at­tract new cus­tomers.

While there are still pre­dic­tions that the dig­i­tal di­rect-to-con­sumer in­dus­try might con­sol­i­date, as some in­dus­try ex­perts are ex­pect­ing this year, Hims & Hers though, one of the few pub­licly trad­ed dig­i­tal health com­pa­nies, like­ly won’t be among the ac­quir­ers, its CEO told End­points News on a re­cent vis­it to San Fran­cis­co, where the com­pa­ny is head­quar­tered.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.